Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ØRSTA SPECSAVERS AS
AS
Active
Org 925937215
Vikegata 17, 6150
Ørsta
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2020 · 5 years old
6 employees
Monitor
Share
Norway
/
Companies
/
Retail sale of medical and orthopaedic goods
/
ØRSTA SPECSAVERS AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
5M
7M
9M
0M
2021
6M
2023
8M
2024
8M
2025
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
NOK thousands
Item
2021
2023
2024
2025
Revenue
0
6 277
8 020
8 418
Staff expenses
−0
−2 764
−2 929
−3 120
EBITDA
−3
−20
479
460
Depreciation & amort.
−0
−448
−726
−726
EBIT
−3
−468
−247
−266
Net financials
0
−68
−88
−87
Profit before tax
−3
−536
−335
−354
Tax
−0
−0
−0
−0
Net profit
−3
−536
−335
−354
Balance sheet
NOK thousands
Item
2021
2023
2024
2025
Total assets
27
3 646
3 154
2 436
Equity
21
−515
−850
−1 203
Long-term debt
0
3 305
2 787
2 250
Short-term debt
6
856
1 217
1 389
Total debt
6
4 161
4 004
3 640
Financial ratios
5-year trend
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
2021
2025
Equity ratio
-49.4%
This company
38.2%
Market median
-229% vs market
2021
2025
Return on equity
-35360700.0%
This company
18.4%
Market median
-192177817% vs market
2021
2025
Net profit margin
-4.2%
This company
8.1%
Market median
-152% vs market
2021
2025
Asset turnover
3.46×
This company
1.12×
Market median
+209% vs market
2021
2025
Debt / equity
3.02×
This company
0.62×
Market median
-387% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-03-01 – 2024-02-29
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2023-02-28
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-09-23 – 2021-12-31
View
PDF
More on ØRSTA SPECSAVERS AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
